文献速递神经创伤神经重症

创伤性脑损伤中普通肝素与低分子肝素血栓预防的颅内出血进展比较

Progression of Intracranial Hemorrhage Comparing Unfractionated Heparin versus Low Molecular Weight Heparin for Chemoprophylaxis in Traumatic Brain Injury.
PubMed 文献 · World Neurosurg · 2025-04-14

该回顾性研究纳入2018年1月至2020年7月在一级创伤中心治疗的335例创伤性脑损伤合并颅内出血患者,比较普通肝素(UFH)与低分子肝素(LMWH)用于静脉血栓栓塞预防时颅内出血进展的风险。结果显示UFH组颅内出血进展率高于LMWH组(6.3% vs 1.7%,P=0.032),UFH组住院时间和ICU时间更长,多因素分析示LMWH与较低的颅内出血进展风险相关(OR 0.262,95%CI 0.071-0.968,P=0.045)。

要点

  • UFH组颅内出血进展率6.3% vs LMWH组1.7%(P=0.032)。
  • UFH组住院时间21.3天 vs LMWH组14.9天(P=0.027)。
  • UFH组ICU时间11.1天 vs LMWH组6.5天(P<0.001)。

核心结论

  • 创伤性脑损伤患者使用LMWH进行静脉血栓栓塞预防与较低的颅内出血进展风险、住院时间和ICU时间相关,相较UFH而言。
  • 尽管队列差异可能有贡献,但在调整风险等级和损伤机制后,LMWH仍独立与较低的颅内出血进展和较短住院时间相关。

研究设计与样本

  • 回顾性综述,纳入2018年1月至2020年7月在一级创伤中心治疗的创伤性脑损伤合并颅内出血患者。
  • 纳入患者有2次或以上头颅CT扫描,并在影像稳定后24小时内接受UFH或LMWH。
  • 共335例患者(女性28%,男性72%),其中160例接受UFH,175例接受LMWH。

主要发现

  • 静脉血栓栓塞预防后颅内出血进展在UFH组更高(6.3% vs 1.7%,P=0.032)。
  • UFH组住院时间21.3天 vs LMWH组14.9天(P=0.027),ICU时间11.1天 vs 6.5天(P<0.001),调整风险等级和损伤机制后仍更长。
  • 多因素分析显示LMWH与较低的颅内出血进展风险相关(OR 0.262,95%CI 0.071-0.968,P=0.045)。
  • 多发病灶患者总体颅内出血进展的比值比更高。

局限性

  • 原文指出队列差异可能有贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to compare the risk of intracranial hemorrhage (ICH) progression in traumatic brain injury (TBI) patients treated with unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) for venous thromboembolism prophylaxis (VTEp). METHODS: A retrospective review was conducted on TBI patients with ICH who were treated at a level 1 trauma center between January 2018 and July 2020. Patients included had 2 or more computed tomography head scans and received either UFH or LMWH within 24 hours after stable imaging. The primary outcome was ICH progression on follow-up computed tomography. Secondary outcomes included hospital and intensive care unit (ICU) length of stay (LOS). RESULTS: Among 335 patients (28% female and 72% male), 160 received UFH and 175 received LMWH. ICH progression after VTEp was higher in the UFH group (6.3% vs. 1.7%, P = 0.032). Hospital LOS and ICU LOS were longer in the UFH group (21.3 vs. 14.9 days, P = 0.027 and 11.1 vs. 6.5 days, P < 0.001, respectively) and remained longer after adjusting for risk level and injury mechanism. Multivariate analysis showed that LMWH was associated with a lower risk of ICH progression (odds ratio: 0.262, 95% confidence interval: 0.071-0.968, P = 0.045). Patients with multifocal lesions had higher odds of overall ICH progression. CONCLUSIONS: VTEp with LMWH in patients with TBI was associated with a lower risk of ICH progression, hospital LOS, and ICU LOS when compared to UFH. While cohort differences may have been contributory, LMWH remained independently associated with lower ICH progression and shorter LOS after adjusting for risk level and injury mechanism.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kittur K, Kumar JI, Salomon K, et al. Progression of Intracranial Hemorrhage Comparing Unfractionated Heparin versus Low Molecular Weight Heparin for Chemoprophylaxis in Traumatic Brain Injury. World Neurosurg. 2025. PMID: 40239859. doi:10.1016/j.wneu.2025.123982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。